Uncomplicated vertex delivery steps
›Normal delivery care
›Head delivery support
›Controlled extension
›Perineal support
›Nuchal cord management
›If loose, slip over head
›If tight and impeding delivery, clamp and cut
›Shoulder delivery
›Gentle downward traction for anterior shoulder
›Gentle upward traction for posterior shoulder
›Newborn transition
›Warm and dry and stimulate
›Hat and skin to skin when stable
›Active management of third stage
›Oxytocin for hemorrhage prevention (FIGO 2022)
Shoulder dystocia management
›Shoulder dystocia algorithm
›Immediate actions
›Call for help and timer
›Avoid fundal pressure
›First line maneuvers
›McRoberts maneuver as initial approach (ACOG referenced summary)
›Suprapubic pressure with McRoberts
›Direction toward posterior aspect of anterior shoulder to rotate into oblique position (NHS Scotland 2022)
›Second line maneuvers
›Posterior arm delivery consideration after McRoberts and suprapubic pressure (AAFP 2020)
›Internal rotational maneuvers
›Rubin maneuver
›Woods corkscrew maneuver
›Rescue maneuvers
›All fours position
›Clavicle fracture intentional avoidance preference
›Post event care
›Neonatal assessment for brachial plexus injury
›Maternal laceration assessment
Breech delivery emergency maneuvers
›Breech at perineum
›General principles
›Hands off until umbilicus delivered when feasible
›Avoid traction on fetal abdomen
›Arm delivery
›Lovset maneuver for nuchal arms
›Head delivery
›Mauriceau Smellie Veit maneuver for head flexion (NHS Scotland 2020)
›Suprapubic pressure assistance for flexion when needed
›Cord compression time sensitivity
›Rapid progression after umbilicus delivery
Postpartum hemorrhage pathway
›PPH initial actions
›Quantitative blood loss measurement (SOGC Guideline No. 431 2022)
›Uterine atony first steps
›Bimanual uterine massage and compression
›Bladder drainage
›Cause framework
›Tone
›Trauma
›Tissue
›Thrombin
Uterotonics and hemostatic medications
›Uterotonic and antifibrinolytic regimen
›Oxytocin
›Initiate 10 IU IM for treatment or prevention options (FIGO 2022)
›Initiate 20 to 40 IU in 1000 mL crystalloid infusion protocol per local guideline (FIGO 2022)
›Adverse effects
›Hypotension with rapid IV bolus
›Methylergonovine
›Initiate 0.2 mg IM
›Contraindications
›Hypertension or preeclampsia
›Carboprost
›Initiate 250 micrograms IM
›Repeat every 15 to 90 min as needed
›Maximum 2 mg total
›Contraindications
›Asthma
›Misoprostol
›Initiate 800 micrograms sublingual when injectable uterotonics unavailable per WHO referenced in midwifery guideline (Ontario Midwives 2024)
›Tranexamic acid
›Initiate 1 g IV as soon as possible and within 3 h of birth for clinically diagnosed PPH (WHO recommendation)
›Repeat 1 g IV if bleeding continues after 30 min or restarts within 24 h (WHO recommendation summary)
Hemorrhage escalation and procedures
›Escalation interventions
›IV access and resuscitation
›Balanced transfusion strategy if massive hemorrhage
›Calcium replacement per massive transfusion protocol
›Laceration management
›Direct pressure and suturing for identified tears
›Vaginal wall packing if diffuse oozing and awaiting OB
›Uterine tamponade
›Balloon tamponade device if available
›Foley balloon as temporizing option
›Uterine inversion
›Immediate manual replacement
›Tocolysis consideration if trapped cervix
›Uterotonic after replacement for tone
›Retained placenta
›OB removal pathway
›Antibiotic prophylaxis per local guideline
Neonatal resuscitation medications and advanced steps
›Neonatal resuscitation escalation
›Positive pressure ventilation
›Begin within 60 s for apnea or gasping or HR < 100 per min (AHA neonatal resuscitation guidance)
›Ventilation corrective steps if no chest rise
›Mask adjustment
›Reposition airway
›Suction mouth then nose
›Open mouth
›Pressure increase
›Alternative airway
›Chest compressions
›Initiate if HR < 60 per min after 30 s effective ventilation (AHA 2020 neonatal resuscitation)
›Ratio 3 to 1 with coordinated ventilation
›Epinephrine
›Umbilical venous catheter preferred
›IV or IO dose range 0.01 to 0.03 mg per kg using 1 mg in 10 mL concentration (NRP medication card)
›ET route as bridge if no vascular access
›Higher dosing required per NRP summary guidance
›Post resuscitation
›Glucose monitoring
›Temperature maintenance
›NICU consult for ongoing respiratory support